• Top Picks
    • Victoza<sup>®</sup> liraglutide (rDNA origin) injection Mechanism of Action
    • Managing Today's EP Challenges with NOAC Use
    • Obesity Consults: Volume 2, Number 3<br/> Biology and Behavior
    • Why Care About Seasonal Influenza in the Age of Ebola?

Select a Topic

  • FILTER BY:
Learn about a multisystem approach to treating your adult patients with type 2 diabetes
VIDEO

Victoza® liraglutide (rDNA origin) injection Mechanism of Action

This activity is sponsored by Novo Nordisk

August 13, 2015

In this video, learn how Victoza®, a GLP-1 receptor agonist, works in the body to compensate for the impaired incretin effect in adult patients with type 2 diabetes…

go to activity»
Avoiding “Loss of Chance”…Improving the Screening, Treatment, and Referral of Patients with Diabetic Retinopathy
CME

Avoiding “Loss of Chance”…Improving the Screening, Treatment, and Referral of Patients with Diabetic Retinopathy

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 7/23/2016
Credit Type(s): CME | Credit: 2

Despite a number of effective treatment options, diabetic eye disease is a leading cause of vision loss in the United States, in part because many patients are not…

go to activity»
Seasonal Influenza
CMECNE

Why Care About Seasonal Influenza in the Age of Ebola?

This activity is supported by an educational grant from Genentech.

February 21, 2015

Seasonal influenza is a serious illness that affects a large number of people annually. Clinicians need to understand it in order to treat it appropriately….

go to activity»
Managing Today's EP Challenges with NOAC Use
CME

Managing Today's EP Challenges with NOAC Use

This activity is supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Daiichi Sankyo, Inc.

Expiration Date: 8/8/2016
Credit Type(s): CME | Credit: 1.25

This engaging activity featuring a superb faculty provides electrophysiologists and others with the best information available on managing stroke prevention around the…

go to activity»
Real-world Use of Anti-VEGF Therapy
CME

Real-world Use of Anti-VEGF Therapy

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 4/25/2016
Credit Type(s): CME | Credit: 1.25

Anti-VEGF is well established as first-line therapy for the treatment of diabetic macular edema (DME) and age-related macular degeneration. What is still being…

go to activity»
Obesity Consults
CME

Obesity Consults: Volume 2, Number 5
Practical Guide to Medications Approved for Chronic Weight Management

This activity is supported by educational grants from Eisai, Inc. and Vivus, Inc.

Expiration Date: 2/1/2016
Credit Type(s): CME | Credit: 1.25

Several pharmacologic options for the management of obesity have been approved by the US FDA, giving clinicians a range of options for managing patients with obesity…

go to activity»
Learn about a multisystem approach to treating your adult patients with type 2 diabetes
VIDEO

Victoza® liraglutide (rDNA origin) injection Mechanism of Action

This activity is sponsored by Novo Nordisk

August 13, 2015

In this video, learn how Victoza®, a GLP-1 receptor agonist, works in the body to compensate for the impaired incretin effect in adult patients with type 2 diabetes…

go to activity»
Managing Today's EP Challenges with NOAC Use
CME

Managing Today's EP Challenges with NOAC Use

This activity is supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Daiichi Sankyo, Inc.

Expiration Date: 8/8/2016
Credit Type(s): CME | Credit: 1.25

This engaging activity featuring a superb faculty provides electrophysiologists and others with the best information available on managing stroke prevention around the…

go to activity»
Avoiding “Loss of Chance”…Improving the Screening, Treatment, and Referral of Patients with Diabetic Retinopathy
CME

Avoiding “Loss of Chance”…Improving the Screening, Treatment, and Referral of Patients with Diabetic Retinopathy

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 7/23/2016
Credit Type(s): CME | Credit: 2

Despite a number of effective treatment options, diabetic eye disease is a leading cause of vision loss in the United States, in part because many patients are not…

go to activity»
Real-world Use of Anti-VEGF Therapy
CME

Real-world Use of Anti-VEGF Therapy

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 4/25/2016
Credit Type(s): CME | Credit: 1.25

Anti-VEGF is well established as first-line therapy for the treatment of diabetic macular edema (DME) and age-related macular degeneration. What is still being…

go to activity»
Seasonal Influenza
CMECNE

Why Care About Seasonal Influenza in the Age of Ebola?

This activity is supported by an educational grant from Genentech.

February 21, 2015

Seasonal influenza is a serious illness that affects a large number of people annually. Clinicians need to understand it in order to treat it appropriately….

go to activity»
Obesity Consults
CME

Obesity Consults: Volume 2, Number 5
Practical Guide to Medications Approved for Chronic Weight Management

This activity is supported by educational grants from Eisai, Inc. and Vivus, Inc.

Expiration Date: 2/1/2016
Credit Type(s): CME | Credit: 1.25

Several pharmacologic options for the management of obesity have been approved by the US FDA, giving clinicians a range of options for managing patients with obesity…

go to activity»
Assessing Cornerstones for Successful Weight Loss
CME

Assessing Cornerstones for Successful Weight Loss: Building a Foundation that Really Works

This activity is supported by an educational grant from Takeda Pharmaceuticals International, Inc., US Region and Orexigen Therapeutics, Inc.

Expiration Date: 1/29/2016
Credit Type(s): CME | Credit: 2

Obesity has increased dramatically in the past 2 decades and is now considered a health care epidemic in the United States, where more than one-third of adults (34.9%)…

go to activity»
Obesity Consults: Volume 2, Number 4 Obesity and the Cardiovascular System
CME

Obesity Consults: Volume 2, Number 4
Obesity and the Cardiovascular System

This activity is supported by an educational grant from Eisai, Inc. and Vivus, Inc.

Expiration Date: 12/15/2015
Credit Type(s): CME | Credit: 1.25

Obesity is associated with a wide range of comorbid conditions, including diabetes, hypertension, sleep apnea, and cardiovascular disease. Clinicians must consider the…

go to activity»
low no
CME

Low- and No-Calorie Sweeteners in Weight Management: What Do You Need to Know?

This activity is supported by an educational grant from the American Beverage Association.

Expiration Date: 12/12/2015
Credit Type(s): CME | Credit: 1

The use of low- and no-calorie sweeteners continues to grow as consumers continue to purchase foods and beverages containing them. Low- and no-calorie sweeteners are…

go to activity»
Obesity Consults: Volume 2, Number 2 Obesity Forum 2014 Highlights
CME

Obesity Consults: Volume 2, Number 2
Obesity Forum 2014 Highlights

This activity is supported by educational grants from Takeda Pharmaceuticals International, Inc., US Region and Orexigen Therapeutics, Inc; Eisai, Inc.; Novo Nordisk; Vivus, Inc.

Expiration Date: 12/1/2015
Credit Type(s): CME | Credit: 1.25

Management of obesity is complex, factoring in psychological, environmental, and physiologic causes. Treatment options include behavior modification, commercially…

go to activity»
Obesity Consults: Volume 2, Number 3
CME

Obesity Consults: Volume 2, Number 3
Biology and Behavior

This activity is supported by an educational grant from Vivus, Inc and Eisai Co., Ltd.

Expiration Date: 12/1/2015
Credit Type(s): CME | Credit: 1.25

Obesity is a complex, multifactorial disease. Understanding how psychology, genetics, biology and neurobiology contribute to weight gain can assist the clinician in…

go to activity»
Obesity Consults: Volume 2, Number 1
CME

Obesity Consults: Volume 2, Number 1

This activity is supported by an educational grant from Vivus, Inc.

Expiration Date: 11/1/2015
Credit Type(s): CME | Credit: 1.25

Obesity is suboptimally managed in clinical practice despite the availability of relevant guidelines and evidence-based interventions. Many physicians remain uncertain…

go to activity»
Acromegaly
CME

Acromegaly Treatment Strategies and Emerging Therapeutic Options

This activity is supported by an educational grant from Genentech.

Expiration Date: 11/30/2015
Credit Type(s): CME | Credit: 0.25

Acromegaly, a rare disease most often caused by the prolonged secretion of excess growth hormone from a pituitary adenoma, is associated with multiple significant…

go to activity»
Fundamentals of Acromegaly
CME

Fundamentals of Acromegaly Pathophysiology and Diagnostic Approaches

This activity is supported by an educational grant from Genentech.

Expiration Date: 11/30/2015
Credit Type(s): CME | Credit: 0.25

Acromegaly, a rare disease most often caused by the prolonged secretion of excess growth hormone from a pituitary adenoma, is associated with multiple significant…

go to activity»
Individualizing T2DM Treatment: Determining Optimal Pathways That Lead to Achieving Target Goals
CME

Individualizing T2DM Treatment: Determining Optimal Pathways That Lead to Achieving Target Goals

This activity is supported by educational grants from Lilly USA, LLC and Novo Nordisk.

Expiration Date: 11/30/2015
Credit Type(s): CME | Credit: 1.5

The prevalence of type 2 diabetes mellitus has escalated in recent years and targeting treatment continues to be a difficult goal. Clinicians will have to become…

go to activity»
Dialogues-In-DiabetesIssues-1 activity
CME

Dialogues in Diabetes: Volume 3, Number 1

Expiration Date: 11/30/2015
Credit Type(s): CME | Credit: 1.25

Contributing factors to the pathophysiologic defects in type 2 diabetes, such as incretin deficiency/resistance in the gastrointestinal tract, accelerated lipolysis in…

go to activity»
HIV-Associated Lipodystrophy and Metabolic Complications: A Multidisciplinary Approach to Diagnosis and Treatment
CME

HIV-Associated Lipodystrophy and Metabolic Complications: A Multidisciplinary Approach to Diagnosis and Treatment

This activity is supported by an educational grant from EMD-Serono.

Expiration Date: 11/30/2015
Credit Type(s): CME | Credit: 1.5

Clinicians who manage patients with HIV must be aware of how to screen for, diagnose, and treat metabolic abnormalities and body shape changes. This monograph will…

go to activity»
Obesity Consults: Volume 1, Number 2
CME

Obesity Consults: Volume 1, Number 2

This activity is supported by an educational grant from Vivus.

Expiration Date: 11/30/2015
Credit Type(s): CME | Credit: 1.25

Obesity has increased dramatically in the past 20 years and is considered a health care epidemic in the United States. One-third of US adults are considered obese…

go to activity»
Practical Lipidology: The Live Forum Pre-Study
CME

Practical Lipidology: The Live Forum Pre-Study

This activity is supported by an educational grant from Genentech.

Expiration Date: 11/30/2015
Credit Type(s): CME | Credit: 1.5

Elevated plasma triglycerides are linked to insulin resistance, and both disorders are associated with increased cardiovascular risk. Experts often debate which…

go to activity»
morganatic-roan